What is AlgaeCytes?
AlgaeCytes is a product-driven enterprise that harnesses proprietary and patentable technology to create and market high-value, vegetarian, health-promoting premium ingredients. Primarily derived from sustainable algae sources, the company specializes in producing high-purity Omega-3 oils, alongside Omega-6 oils, antioxidants, and proteins. These ingredients are targeted for use in the health care, personal care, and pharmaceutical sectors, with its production technology holding potential for broader market applications.
How much funding has AlgaeCytes raised?
AlgaeCytes has raised a total of $18.3M across 1 funding round:
Other Financing Round
$18.3M
Other Financing Round (2022): $18.3M with participation from IBG GLOBAL
Key Investors in AlgaeCytes
IBG GLOBAL
IBG Global is a leading international business development consulting firm specializing in global expansion strategies, export consulting, and trade services. Established in 2002, it operates a global network of 21 independently owned consultancies, providing services to exporters and investment promotion marketing to economic development agencies.
What's next for AlgaeCytes?
The recent major strategic investment positions AlgaeCytes for accelerated growth and market penetration. This capital will likely fuel further research and development into novel algae-derived compounds, scale up production capabilities to meet increasing demand, and expand its global distribution network. The company's focus on high-purity Omega-3 oils and other valuable biomolecules suggests a strategic push to capture a larger share of the rapidly growing nutraceutical and cosmeceutical markets. Future endeavors may include exploring new therapeutic applications for its unique compounds and forging strategic partnerships to enhance market reach.
See full AlgaeCytes company page
